136 related articles for article (PubMed ID: 2460231)
1. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.
Bazinet M; Cote RJ; Cordon-Cardo C; Myc A; Fair WR; Old LJ
Cancer Res; 1988 Dec; 48(23):6938-42. PubMed ID: 2460231
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
Horoszewicz JS; Kawinski E; Murphy GP
Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
[TBL] [Abstract][Full Text] [Related]
3. Production of monoclonal antibody against human prostatic adenocarcinoma and its immunohistochemical properties.
Matsuki H; Ozono S; Yoshie T; Kubota K; Hirao Y; Konishi N; Hashimoto H; Ohshima M; Hiasa Y; Okajima E
Jpn J Exp Med; 1990 Oct; 60(5):263-72. PubMed ID: 1706786
[TBL] [Abstract][Full Text] [Related]
4. Human prostate tissue antigens defined by murine monoclonal antibodies.
Starling JJ; Sieg SM; Beckett ML; Wirth PR; Wahab Z; Schellhammer PF; Ladaga LE; Poleskic S; Wright GL
Cancer Res; 1986 Jan; 46(1):367-74. PubMed ID: 2415250
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas.
Beckett ML; Lipford GB; Haley CL; Schellhammer PF; Wright GL
Cancer Res; 1991 Feb; 51(4):1326-33. PubMed ID: 1705172
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a monoclonal antibody, KR-P8, that detects a new prostate-specific marker.
Raynor RH; Hazra TA; Moncure CW; Mohanakumar T
J Natl Cancer Inst; 1984 Sep; 73(3):617-25. PubMed ID: 6206270
[TBL] [Abstract][Full Text] [Related]
8. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
9. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5.
Lopes AD; Davis WL; Rosenstraus MJ; Uveges AJ; Gilman SC
Cancer Res; 1990 Oct; 50(19):6423-9. PubMed ID: 1698122
[TBL] [Abstract][Full Text] [Related]
11. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins.
Partin AW; Briggman JV; Subong EN; Szaro R; Oreper A; Wiesbrock S; Meyer J; Coffey DS; Epstein JI
Urology; 1997 Nov; 50(5):800-8. PubMed ID: 9372899
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
13. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
[TBL] [Abstract][Full Text] [Related]
14. [Human prostatic tissue specific antigens: a model for the research of monoclonal antibodies against unknown antigens].
Yoshiki T; Okada Y; Tomoyoshi T; Ueda M; Ogawa O; Yoshida O
Hinyokika Kiyo; 1993 Mar; 39(3):213-9. PubMed ID: 7685139
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to a human prostate antigen.
Frankel AE; Rouse RV; Wang MC; Chu TM; Herzenberg LA
Cancer Res; 1982 Sep; 42(9):3714-8. PubMed ID: 6179608
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
18. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody PR92 with restricted specificity for tumor-associated antigen of prostate and breast carcinoma.
Kim YD; Robinson DY; Tomita JT
Cancer Res; 1988 Aug; 48(16):4543-8. PubMed ID: 3396007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
